Trial Site Detail
Drug: |
LBH589 |
|||
|---|---|---|---|---|
Trial: |
A Phase IA, two-arm, multi-center, dose escalating study of LBH589 administered intravenously on two dose schedules in adult patients with advanced solid tumors & non-Hodgkin’s lymphoma. |
|||
| Conditions: | Advanced Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Nevada Cancer Institute10441 W Twain Ave |
Principal Investigator: |
Sunil Sharma M.D. |
|---|---|
Contact: |
Donna Adkins (702) 822-5173 dadkins@nvcancer.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Nevada Cancer Institute Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.